Abstract
Gap junctional intercellular communication is a mechanism for direct cell-to-cell signaling and is mediated by gap junctions, which consist of transmembrane proteins called connexins. Many physiological roles have been proposed for gap junctions such as maintenance of tissue homeostasis, regulation of tissue development, electrical and metabolic coupling as well as regulation of cellular growth, differentiation and apoptosis. Signaling is especially altered via gap junctions in cancer. Furthermore, these membrane channels are believed to be engaged in metastasis. Involvement of aberrant gap junctional intercellular communication in carcinogenesis and tumor suppressing role of connexin genes has been well documented. However, clear explanation is required for the role of connexins that are localized in intracellular compartment of cancerous cells and participate in apoptosis and metastasis as well. The present review is confined to role of connexins in a cell signaling during carcinogenesis, regulation of apoptosis and involvement in metastasis. Potential role of gap junctions and connexins in therapy of cancers was analyzed, too.
Keywords: Connexin, gap junction, carcinogenesis, cancer
Current Signal Transduction Therapy
Title: The Role of Connexins in Carcinogenesis: Review of Current Knowledge
Volume: 2 Issue: 1
Author(s): Kanczuga-koda Luiza, Sulkowski Stanislaw, Koda Mariusz, Wincewicz Andrzej, Rutkowski Tadeusz and Moniuszko Mariola
Affiliation:
Keywords: Connexin, gap junction, carcinogenesis, cancer
Abstract: Gap junctional intercellular communication is a mechanism for direct cell-to-cell signaling and is mediated by gap junctions, which consist of transmembrane proteins called connexins. Many physiological roles have been proposed for gap junctions such as maintenance of tissue homeostasis, regulation of tissue development, electrical and metabolic coupling as well as regulation of cellular growth, differentiation and apoptosis. Signaling is especially altered via gap junctions in cancer. Furthermore, these membrane channels are believed to be engaged in metastasis. Involvement of aberrant gap junctional intercellular communication in carcinogenesis and tumor suppressing role of connexin genes has been well documented. However, clear explanation is required for the role of connexins that are localized in intracellular compartment of cancerous cells and participate in apoptosis and metastasis as well. The present review is confined to role of connexins in a cell signaling during carcinogenesis, regulation of apoptosis and involvement in metastasis. Potential role of gap junctions and connexins in therapy of cancers was analyzed, too.
Export Options
About this article
Cite this article as:
Luiza Kanczuga-koda, Stanislaw Sulkowski, Mariusz Koda, Andrzej Wincewicz, Tadeusz Rutkowski and Mariola Moniuszko, The Role of Connexins in Carcinogenesis: Review of Current Knowledge, Current Signal Transduction Therapy 2007; 2 (1) . https://dx.doi.org/10.2174/157436207779317074
DOI https://dx.doi.org/10.2174/157436207779317074 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advances in Nanomedicine Towards Clinical Application in Oncology and Immunology
Current Pharmaceutical Biotechnology Recent Advances in the Synthesis and Applications of Multimodal Gold-Iron Nanoparticles
Current Medicinal Chemistry Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis
Current Drug Targets Comparison of Radiohaloanalogues of Meta-Iodobenzylguanidine (MIBG) for a Combined Gene- and Targeted Radiotherapy Approach to Bladder Carcinoma
Medicinal Chemistry Recent Development of Oridonin Derivatives with Diverse Pharmacological Activities
Mini-Reviews in Medicinal Chemistry The Potential Role of Pharmacogenomic and Genomic in the Adjuvant Treatment of Early Stage Non Small Cell Lung Cancer
Current Genomics Molecular Biomarkers for Lung Adenocarcinoma: A Short Review
Current Cancer Therapy Reviews Signaling Through Rho GTPase Pathway as Viable Drug Target
Current Medicinal Chemistry Intravesical Therapy of Superficial Bladder Cancer
Current Pharmaceutical Design Targeting the Nucleotide Metabolism Proteins of the NUDIX Family and SAMHD1 in Cancer
Current Medicinal Chemistry Pharmacotherapy in Systemic Lupus Erythematosus
Current Rheumatology Reviews A Search for Inhibitors of S100B, a Member of the S100 Family of Calcium-Binding Proteins
Mini-Reviews in Medicinal Chemistry Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy
Current Cancer Drug Targets Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex
Current Cancer Drug Targets The Preclinical Bases of the Rational Combination of Paclitaxel and Antiangiogenic Drugs
Clinical Cancer Drugs Statins and Cancer
Anti-Cancer Agents in Medicinal Chemistry Development of Metal-Based Drugs and Application in Clinical Treatment
The Natural Products Journal Biomolecules Linked to Transition Metal Complexes - New Chances for Chemotherapy
Current Medicinal Chemistry Histone Deacetylase Inhibitors as Potent Modulators of Cellular Contacts
Current Drug Targets Thermodynamic and Kinetic Aspects Involved in the Development of Nanocarriers and Drug Delivery Systems Based on Cationic Biopolymers
Current Pharmaceutical Design